Why Healthcare AI May Be Stuck in a Bot-vs-Bot Phase
MedCity News argues that healthcare AI is hitting a plateau because systems are increasingly optimized for machines talking to machines rather than for clinicians and patients. The result is progress that looks impressive in demos but stalls in day-to-day care. The story captures a key tension in the field: interoperability and automation are not the same thing as clinical usefulness.
Healthcare AI has entered a strange phase. On paper, the tools are more capable than ever, but in practice many systems still struggle to produce outcomes that feel transformative at the bedside or in the billing office. That disconnect is what makes the “bot vs. bot” framing so apt: increasingly, AI is being asked to work around other AI systems, not around the human problems health care is supposed to solve.
This matters because healthcare workflows are layered with automation already—prior authorization engines, revenue-cycle software, scheduling systems, risk stratification tools, and documentation platforms. If a new AI model only learns how to negotiate with existing software stacks, its benefit can be hard to detect. It may reduce friction in one corner while creating complexity in another.
The risk is that the industry confuses technical sophistication with operational progress. A model that performs well in a benchmark or closed pilot may still fail once it encounters incomplete records, edge cases, clinician skepticism, or regulatory scrutiny. In health care, reliability and trust are often more valuable than raw capability.
If the sector is stuck, the cure is not bigger models alone. It is better product design, clearer use cases, stronger evidence, and workflow ownership by the people who actually deliver care. Until those pieces line up, healthcare AI may remain impressive in theory and underwhelming in execution.